A human memory T cell subset with stem cell–like properties

Cited by (1,001)

Items 201–300 of 1,001

1. Cholesterol negatively regulates IL-9–producing CD8+ T cell differentiation and antitumor activity
   Xingzhe Ma, Enguang Bi, Chunjian Huang, Yong Lu, Gang Xue, Xingrong Guo, Aibo Wang, Maojie Yang, Jianfei Qian, Chen Dong et al. · 2018 · The Journal of Experimental Medicine
2. Chimeric Antigen Receptor Designed to Prevent Ubiquitination and Downregulation Showed Durable Antitumor Efficacy
   Wentao Li, Shizhen Qiu, Jian Chen, Shutan Jiang, Wendong Chen, Jingwei Jiang, Fei Wang, Wen Si, Yilai Shu, Ping Wei et al. · 2020 · Immunity
3. Genetically modified T cells in cancer therapy: opportunities and challenges
   Michaela E. Sharpe, Natalie M. Mount · 2015 · Disease Models & Mechanisms
4. T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapy
   Yamamoto, Tori N., Lee, Ping-Hsien, Vodnala, Suman K., Gurusamy, Devikala, Kishton, Rigel J., Yu, Zhiya, Eidizadeh, Arash, Eil, Robert, Fioravanti, Jessica, Gattinoni, Luca et al. · 2019 · Journal of Clinical Investigation
5. Current status of latency reversing agents facing the heterogeneity of HIV-1 cellular and tissue reservoirs
   Ait-Ammar, Amina, Kula, Anna, Darcis, Gilles, Verdikt, Roxane, De Wit, Stephane, Gautier, Virginie, Mallon, Patrick W. G., Marcello, Alessandro, Rohr, Olivier, Van Lint, Carine · 2020 · Frontiers in Microbiology
6. Melanoma Persister Cells Are Tolerant to BRAF/MEK Inhibitors via ACOX1-Mediated Fatty Acid Oxidation
   Shensi Shen, Sara Faouzi, Sylvie Souquère, Severine Roy, Émilie Routier, Cristina Libenciuc, Fabrice André, Gérard Pierron, Jean‐Yves Scoazec, Caroline Robert · 2020 · Cell Reports
7. Immune markers and correlates of protection for vaccine induced immune responses
   Aneesh Thakur, Lasse Eggers Pedersen, Gregers Jungersen · 2012 · Vaccine
8. T cell receptor therapeutics: immunological targeting of the intracellular cancer proteome
   Christopher Austin Klebanoff, Smita S. Chandran, Brian M. Baker, Sergio A. Quezada, Antoni Ribas · 2023 · Nature Reviews Drug Discovery
9. Quantitation of Replication-Competent HIV-1 in Populations of Resting CD4 + T Cells
   Natalia Soriano-Sarabia, Rosalie Bateson, Noelle Dahl, Amanda M. Crooks, JoAnn D. Kuruc, David M. Margolis, Nancie M. Archin · 2014 · Journal of Virology
10. The Latent Reservoir for HIV-1: How Immunologic Memory and Clonal Expansion Contribute to HIV-1 Persistence
    Alexandra J Murray, Kyungyoon J. Kwon, Donna L. Färber, Robert F. Siliciano · 2016 · The Journal of Immunology
11. Multi-phenotype CRISPR-Cas9 Screen Identifies p38 Kinase as a Target for Adoptive Immunotherapies
    Devikala Gurusamy, Amanda N. Henning, Tori N. Yamamoto, Zhiya Yu, Nikolaos Zacharakis, Sri Krishna, Rigel J. Kishton, Suman Kumar Vodnala, Arash Eidizadeh, Li Jia et al. · 2020 · Cancer Cell
12. Cytokine release syndrome in cancer immunotherapy with chimeric antigen receptor engineered T cells
    Xu, Xiao-Jun, Tang, Yong-Min · 2014 · Cancer Letters
13. T Cell Fate at the Single-Cell Level
    Veit R. Buchholz, Ton N. Schumacher, Dirk Hans Busch · 2015 · Annual Review of Immunology
14. HIV DNA Is Frequently Present within Pathologic Tissues Evaluated at Autopsy from Combined Antiretroviral Therapy-Treated Patients with Undetectable Viral Loads
    Susanna L. Lamers, Rebecca Rose, Ekaterina Maidji, Melissa Agsalda‐Garcia, David J. Nolan, Gary B. Fogel, Marco Salemi, Debra Leiolani Garcia, Paige M. Bracci, William H. Yong et al. · 2016 · Journal of Virology
15. Targeting cancers through TCR-peptide/MHC interactions
    Qinghua He, Xianhan Jiang, Xinke Zhou, Jinsheng Weng · 2019 · Journal of Hematology & Oncology
16. Exercise and the immune system: taking steps to improve responses to cancer immunotherapy
    Michael P. Gustafson, Courtney M. Wheatley, Allison Claire Rosenthal, Dennis A. Gastineau, Emmanuel Katsanis, Bruce D. Johnson, Richard J. Simpson · 2021 · Journal for ImmunoTherapy of Cancer
17. Enhanced T cell effector activity by targeting the Mediator kinase module
    Katherine A. Freitas, Julia A. Belk, Elena Sotillo, Patrick J. Quinn, Maria Cecilia Ramello, Meena B. Malipatlolla, Bence Dániel, Katalin D. Sandor, Dorota Danuta Klysz, Jeremy R. Bjelajac et al. · 2022 · Science
18. Design and implementation of adoptive therapy with chimeric antigen receptor‐modified T cells
    Michael C. Jensen, Stanley R. Riddell · 2013 · Immunological Reviews
19. Adoptive immunotherapy for cancer
    M. Ruella, M. Kalos · 2014 · Immunological Reviews
20. An intercellular transfer of telomeres rescues T cells from senescence and promotes long-term immunological memory
    Alessio Lanna, Bruno Vaz, Clara D’Ambra, Salvatore Valvo, Claudia Vuotto, Valerio Chiurchiù, Oliver Devine, Massimo Sanchez, Giovanna Borsellino, Arne N. Akbar et al. · 2022 · Nature Cell Biology
21. Expansion of T memory stem cells with superior anti-tumor immunity by Urolithin A-induced mitophagy
    Dominic Denk, Valentina Petrocelli, Claire Conche, Moritz Wolfgang Drachsler, Paul K. Ziegler, Angela Braun, Alena Kress, Adele M. Nicolas, Kathleen Mohs, Christoph Becker et al. · 2022 · Immunity
22. Transcript-indexed ATAC-seq for precision immune profiling
    Satpathy, Ansuman T., Saligrama, Naresha, Buenrostro, Jason D., Wei, Yuning, Wu, Beijing, Rubin, Adam J., Granja, Jeffrey M., Lareau, Caleb A., Li, Rui, Qi, Yanyan et al. · 2018 · Nature Medicine
23. CD4 + T Cells from IPEX Patients Convert into Functional and Stable Regulatory T Cells by FOXP3 Gene Transfer
    Laura Passerini, Eva Rossi Mel, Claudia Sartirana, Georgia Fousteri, Attilio Bondanza, Luigi Naldini, Maria Grazia Roncarolo, Rosa Bacchetta · 2013 · Science Translational Medicine
24. Transcriptional and Epigenetic Regulation of Effector and Memory CD8 T Cell Differentiation
    Yao Chen, Ryan Zander, Achia Khatun, David Schauder, Weiguo Cui · 2018 · Frontiers in Immunology
25. Engineering Stimuli‐Activatable Boolean Logic Prodrug Nanoparticles for Combination Cancer Immunotherapy
    Bo Hou, Lei Zhou, Hui Wang, Madiha Saeed, Dangge Wang, Zhiai Xu, Yaping Li, Haijun Yu · 2020 · Advanced Materials
26. Clonal expansion of T memory stem cells determines early anti-leukemic responses and long-term CAR T cell persistence in patients
    L. Biasco, N. Izotova, C. Rivat, S. Ghorashian, R. Richardson, A. Guvenel, R. Hough, R. Wynn, B. Popova, Andre Lopes et al. · 2021 · Nature Cancer
27. IL-7 in human health and disease
    Wangko Lundström, Natasha M. Fewkes, Crystal Lee Mackall · 2012 · Seminars in Immunology
28. Point-of-care CAR T-cell production (ARI-0001) using a closed semi-automatic bioreactor: Experience from an academic phase I clinical trial
    Castella, Maria, Caballero-Baños, Miguel, Ortiz-Maldonado, Valentín, González-Navarro, Europa Azucena, Suñé, Guillermo, Antoñana-Vidósola, Asier, Boronat, Anna, Marzal, Berta, Millán, Lucía, Martín-Antonio, Beatriz et al. · 2020 · Frontiers in Immunology
29. Role of naive-derived T memory stem cells in T-cell reconstitution following allogeneic transplantation
    Alessandra Roberto, Luca Castagna, Veronica Zanon, Stéfania Bramanti, Roberto Crocchiolo, James E. McLaren, Sara Gandolfi, Paolo Tentorio, Barbara Sarina, Inna Timofeeva et al. · 2015 · Blood
30. Cytokine and Chemokine Signals of T‐Cell Exclusion in Tumors
    Zhang, Yu, Guan, Xin-yuan, Jiang, Peng · 2020 · Frontiers in Immunology
31. Induction of a central memory and stem cell memory phenotype in functionally active CD4+ and CD8+ CAR T cells produced in an automated good manufacturing practice system for the treatment of CD19+ acute lymphoblastic leukemia
    Blaeschke, Franziska, Stenger, Dana, Kaeuferle, Theresa, Willier, Semjon, Lotfi, Ramin, Kaiser, Andrew Didier, Assenmacher, Mario, Döring, Michaela, Feucht, Judith, Feuchtinger, Tobias · 2018 · Cancer Immunology, Immunotherapy
32. Human memory CD8 T cell effector potential is epigenetically preserved during in vivo homeostasis
    Hossam Aly Abdelsamed, Ardiana Moustaki, Yiping Fan, Pranay Dogra, Hazem E. Ghoneim, Caitlin C. Zebley, Brandon Matthew Triplett, Rafick‐Pierre Sékaly, Ben Youngblood · 2017 · The Journal of Experimental Medicine
33. Resident and circulating memory T cells persist for years in melanoma patients with durable responses to immunotherapy
    Jichang Han, Yanding Zhao, Keisuke Shirai, Aleksey K. Molodtsov, Fred Kolling, Jan L. Fisher, Peisheng Zhang, Shaofeng Yan, Tyler G. Searles, Justin M. Bader et al. · 2021 · Nature Cancer
34. The three main stumbling blocks for anticancer T cells
    Lukas Baitsch, Silvia A. Fuertes Marraco, Amandine Legat, Christiane Meyer, Daniel E. Speiser · 2012 · Trends in Immunology
35. Extracellular acidosis restricts one-carbon metabolism and preserves T cell stemness
    Hongcheng Cheng, Yajing Qiu, Yue Xu, Li Chen, Kaili Ma, Mengyuan Tao, Luke S. Frankiw, Hongli Yin, Ermei Xie, Xiaoli Pan et al. · 2023 · Nature Metabolism
36. Emerging concepts in tissue-resident T cells: lessons from humans
    Joseph J.C. Thome, Donna L. Färber · 2015 · Trends in Immunology
37. Current Advances in T-Cell-Based Cancer Immunotherapy
    Mingjun Wang, Bingnan Yin, Helen Y. Wang, Rong‐Fu Wang · 2014 · Immunotherapy
38. Phenotypic and Functional Attributes of Lentivirus-modified CD19-specific Human CD8+ Central Memory T Cells Manufactured at Clinical Scale
    Xiuli Wang, Araceli Naranjo, Christine E. Brown, Cherrilyn Bautista, ChingLam W. Wong, Wen-Chung Chang, Brenda Aguilar, Julie R. Ostberg, Stanley R. Riddell, Stephen J. Forman et al. · 2012 · Journal of Immunotherapy
39. Optimizing Manufacturing Protocols of Chimeric Antigen Receptor T Cells for Improved Anticancer Immunotherapy
    Sophia Stock, Michael W. Schmitt, Leopold Sellner · 2019 · International Journal of Molecular Sciences
40. Fundamentals of T Cell Metabolism and Strategies to Enhance Cancer Immunotherapy
    Guillermo O. Rangel Rivera, Hannah M. Knochelmann, Connor J. Dwyer, Aubrey S. Smith, Megan M. Wyatt, Amalia M. Rivera-Reyes, Jessica E. Thaxton, Chrystal Mary Paulos · 2021 · Frontiers in Immunology
41. Chimeric Antigen Receptor (CAR) T Cells: Lessons Learned from Targeting of CD19 in B-Cell Malignancies
    Kevin Anthony Hay, Cameron John Turtle · 2017 · Drugs
42. A Novel Autologous CAR-T Therapy, YTB323, with Preserved T-cell Stemness Shows Enhanced CAR T-cell Efficacy in Preclinical and Early Clinical Development
    Michael John Dickinson, Pere Barba, Ulrich Jaeger, Nirav Niranjan Shah, Didier Blaise, Javier Briones, Leyla Osman Shune, Nicolas Boissel, Attilio Bondanza, Luisa Mariconti et al. · 2023 · Cancer Discovery
43. Consensus nomenclature for CD8+T cell phenotypes in cancer
    Lionel Apétoh, Mark John Smyth, Charles G. Drake, Jean‐Pierre Abastado, Ron N. Apte, Maha Ayyoub, Jean‐Yves Blay, Marc Bonneville, Lisa Helene Butterfield, Anne Caignard et al. · 2015 · OncoImmunology
44. Impact of age, sex and CMV-infection on peripheral T cell phenotypes: results from the Berlin BASE-II Study
    Di Benedetto, Svetlana, Derhovanessian, Evelyna, Steinhagen-Thiessen, Elisabeth, Goldeck, David, Müller, Ludmila, Pawelec, Graham · 2015 · Biogerontology
45. IL15 and T-cell Stemness in T-cell–Based Cancer Immunotherapy
    Karolina Pilipow, Alessandra Roberto, Mario Roederer, Thomas A. Waldmann, Domenico Mavilio, Enrico Lugli · 2015 · Cancer Research
46. HIV-1 Reservoirs During Suppressive Therapy
    Kirston Barton, Anni Assing Winckelmann, Sarah Palmer · 2016 · Trends in Microbiology
47. ZEBs: Novel Players in Immune Cell Development and Function
    Charlotte L. Scott, Kyla D. Omilusik · 2019 · Trends in Immunology
48. Tumor-associated factors are enriched in lymphatic exudate compared to plasma in metastatic melanoma patients
    Maria A.S. Broggi, Léa Maillat, Cristina Corina Clement, Natacha Bordry, Patricia Corthésy, Aymeric Auger, Maurice Matter, Romain Hamelin, Lambert Potin, Davide Demurtas et al. · 2019 · The Journal of Experimental Medicine
49. Generation of human memory stem T cells after haploidentical T-replete hematopoietic stem cell transplantation
    Nicoletta Cieri, Giacomo Oliveira, Raffaella Greco, Mattia Forcato, Cristian Taccioli, Beatrice Claudia Cianciotti, Veronica Valtolina, Maddalena Noviello, Luca Vago, Attilio Bondanza et al. · 2015 · Blood
50. CD8+ T Lymphocyte Self-Renewal during Effector Cell Determination
    Wen-Hsuan Wendy Lin, Simone A. Nish, Bonnie Yen, Yen‐Hua Chen, William C. T. Adams, Radomir Kratchmarov, Nyanza J. Rothman, Avinash Bhandoola, Hai‐Hui Xue, Steven L. Reiner · 2016 · Cell Reports
51. Genetic ablation of PRDM1 in antitumor T cells enhances therapeutic efficacy of adoptive immunotherapy
    Toshiaki Yoshikawa, Zhiwen Wu, Satoshi Inoue, Hitomi Kasuya, Hirokazu Matsushita, Yusuke Takahashi, Hiroaki Kuroda, Waki Hosoda, Shiro Suzuki, Yuki Kagoya · 2021 · Blood
52. BLIMP1 and NR4A3 transcription factors reciprocally regulate antitumor CAR T cell stemness and exhaustion
    In-Young Jung, Vivek Narayan, Sierra McDonald, Andrew J. Rech, Robert L. Bartoszek, Gwanui Hong, Megan M. Suhoski, Jun Xu, Alina C. Boesteanu, Julie S. Barber-Rotenberg et al. · 2022 · Science Translational Medicine
53. Shared and distinct transcriptional programs underlie the hybrid nature of iNKT cells
    Nadia R. Cohen, Patrick J. Brennan, Tal Shay, Gerald F Watts, Manfred Brigl, Joonsoo Kang, Michael B. Brenner · 2012 · Nature Immunology
54. Antioxidant metabolism regulates CD8+ T memory stem cell formation and antitumor immunity
    Karolina Pilipow, Eloise Scamardella, Simone Puccio, Sanjivan Gautam, Fédérica De Paoli, Emilia Maria Cristina Mazza, Gabriele De Simone, Sara Polletti, Marta Buccilli, Veronica Zanon et al. · 2018 · JCI Insight
55. Targeting innate immunity for tuberculosis vaccination
    Shabaana A. Khader, Maziar Divangahi, Willem Albert Hanekom, Philip C. Hill, Markus J. Maeurer, Karen W. Makar, Katrin D. Mayer-Barber, Musa M. Mhlanga, Elisa Nemes, Larry S. Schlesinger et al. · 2019 · Journal of Clinical Investigation
56. Progressive contraction of the latent HIV reservoir around a core of less-differentiated CD4+ memory T Cells
    Salma Jaafoura, M. G. de Goër de Herve, Esteban Abelardo Hernandez-Vargas, Houria Hendel, Momen Abdoh, M. C. Mateo, Roman Krzysiek, Mansouria Merad-Boudia, R. Seng, Marc Tardieu et al. · 2014 · Nature Communications
57. Beyond model antigens: high-dimensional methods for the analysis of antigen-specific T cells
    Evan William Newell, Mark M. Davis · 2014 · Nature Biotechnology
58. Biology of IL-2 and its therapeutic modulation: Mechanisms and strategies
    Suman Mitra, Warren J. Leonard · 2018 · Journal of Leukocyte Biology
59. Metabolic communication in tumors: a new layer of immunoregulation for immune evasion
    Ho, Ping-Chih, Liu, Pu-Ste · 2016 · Journal for ImmunoTherapy of Cancer
60. Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell and tumor-localized IL-12 immunotherapy
    Vipul Bhatia, Nikhil V. Kamat, Tiffany E. Pariva, Liting Wu, Annabelle Tsao, Koichi Sasaki, Huiyun Sun, Gerardo Javier, W. Sam Nutt, Ilsa M. Coleman et al. · 2023 · Nature Communications
61. Differential infection patterns of CD4+ T cells and lymphoid tissue viral burden distinguish progressive and nonprogressive lentiviral infections
    Jason M. Brenchley, Carol L. Vinton, Brian Tabb, Xingpei Hao, Elizabeth Connick, Mirko Paiardini, Jeffrey D. Lifson, Guido Silvestri, Jacob D. Estes · 2012 · Blood
62. Rapid Salvage Treatment With Virus-Specific T Cells for Therapy-Resistant Disease
    Michael Uhlin, Jens Gertow, Mehmet Uzunel, Mantas Okas, Sofia Berglund, Emma Watz, Mats L. Brune, Per T Ljungman, Markus J. Maeurer, Jonas Mattsson · 2012 · Clinical Infectious Diseases
63. Peptide-mediated delivery of CRISPR enzymes for the efficient editing of primary human lymphocytes
    Dana Vera Foss, Joseph J. Muldoon, David N. Nguyen, Daniel Carr, Srishti U. Sahu, John M. Hunsinger, Stacia K. Wyman, Netravathi Krishnappa, Rima Mendonsa, Elaine V. Schanzer et al. · 2023 · Nature Biomedical Engineering
64. Ezh2 phosphorylation state determines its capacity to maintain CD8+ T memory precursors for antitumor immunity
    Shan He, Yongnian Liu, Lijun Meng, Hongxing Sun, Ying Wang, Yun Ji, Janaki Purushe, Pan Chen, Changhong Li, Jozef Madžo et al. · 2017 · Nature Communications
65. Barriers for HIV Cure: The Latent Reservoir
    Sergio Castro‐Gonzalez, Marta Colomer-Lluch, Ruth Serra-Moreno · 2018 · AIDS Research and Human Retroviruses
66. The Unsolved Jigsaw Puzzle of the Immune Response in Chagas Disease
    Gonzalo Raúl Acevedo, Magalí C. Girard, Karina A. Gómez · 2018 · Frontiers in Immunology
67. Interleukin-15 enhances the proliferation, stimulatory phenotype, and antitumor effector functions of human gamma delta T cells
    Heleen H. Van Acker, Sébastien Anguille, Yannick Willemen, Johan M.J. Van den Bergh, Zwi Nisan Berneman, Eva Lion, Evelien Smits, Viggo F. Van Tendeloo · 2016 · Journal of Hematology & Oncology
68. TNF-α/IFN-γ profile of HBV-specific CD4 T cells is associated with liver damage and viral clearance in chronic HBV infection
    Haoliang Wang, Heng Luo, Xing Wan, Xiaolan Fu, Qing Mao, Xiaomei Xiang, Yi Zhou, Weiwei He, Juan Zhang, Yanzhi Guo et al. · 2019 · Journal of Hepatology
69. The Future Is Now: Chimeric Antigen Receptors as New Targeted Therapies for Childhood Cancer
    Daniel W. Lee, David Maxwell Barrett, Crystal Lee Mackall, Rimas J. Orentas, Stephan A. Grupp · 2012 · Clinical Cancer Research
70. CD4 T Cells with Effector Memory Phenotype and Function Develop in the Sterile Environment of the Fetus
    Xiaoming Zhang, Brian Mozeleski, Sébastien Lemoine, Edith Dériaud, Annick Lim, Dania Zhivaki, Élie Azria, Camille Le Ray, Gwénaëlle Roguet, Odile Launay et al. · 2014 · Science Translational Medicine
71. Regeneration of CD8αβ T Cells from T-cell–Derived iPSC Imparts Potent Tumor Antigen-Specific Cytotoxicity
    Takuya Maeda, Seiji Nagano, Hiroshi Ichise, Keisuke Kataoka, Daisuke Yamada, Seishi Ogawa, Haruhiko Koseki, Toshio Kitawaki, Norimitsu Kadowaki, Akifumi Takaori‐Kondo et al. · 2016 · Cancer Research
72. Low interleukin-2 concentration favors generation of early memory T cells over effector phenotypes during chimeric antigen receptor T-cell expansion
    Tanja Kaartinen, Annu Luostarinen, Pilvi Maliniemi, Joni Keto, Mikko Arvas, Heini Belt, Jonna Koponen, Angelica Loskog, Satu M. Mustjoki, Kimmo Porkka et al. · 2017 · Cytotherapy
73. The chimeric TAC receptor co-opts the T cell receptor yielding robust anti-tumor activity without toxicity
    Christopher W. Helsen, Joanne A. Hammill, Vivian Wing Chong Lau, Kenneth A. Mwawasi, Arya Afsahi, Ksenia Bezverbnaya, Lisa Newhook, Danielle L Hayes, Craig W Aarts, Bojana Bojović et al. · 2018 · Nature Communications
74. Immunological memory cells
    Weronika Ratajczak, Paulina Niedźwiedzka‐Rystwej, Beata Tokarz–Deptuła, Wiesław Deptuła · 2018 · Central European Journal of Immunology
75. CAR T Cells in Trials: Recent Achievements and Challenges that Remain in the Production of Modified T Cells for Clinical Applications
    Ulrike Koehl, Stanislava Arsenieva, Astrid Holzinger, Hinrich Abken · 2018 · Human Gene Therapy
76. Modulation of mTOR Signalling Triggers the Formation of Stem Cell-like Memory T Cells
    Godehard Scholz, Camilla Jandus, Lianjun Zhang, Camille Grandclément, Isabel C. López‐Mejía, Charlotte Soneson, Mauro Delorenzi, Lluís Fajas, Werner Held, Olivier Dormond et al. · 2016 · EBioMedicine
77. Activation of miR-21-Regulated Pathways in Immune Aging Selects against Signatures Characteristic of Memory T Cells
    Chulwoo Kim, Bin Hu, Rohit R. Jadhav, Jun Jin, Huimin Zhang, Mary Cavanagh, Rama S. Akondy, Rafi Ahmed, Cornelia M. Weyand, Jörg J. Goronzy · 2018 · Cell Reports
78. Beta cell-specific CD8+ T cells maintain stem cell memory-associated epigenetic programs during type 1 diabetes
    Abdelsamed, Hossam A., Zebley, Caitlin C., Nguyen, Hai, Rutishauser, Rachel L., Fan, Yiping, Ghoneim, Hazem E., Crawford, Jeremy Chase, Alfei, Francesca, Alli, Shanta, Ribeiro, Susan Pereira et al. · 2020 · Nature Immunology
79. A unified atlas of CD8 T cell dysfunctional states in cancer and infection
    Yuri Pritykin, Joris van der Veeken, Allison R. Pine, Yi Zhong, Merve Şahin, Linas Mažutis, Dana Pe’er, Alexander Yu Rudensky, Christina S. Leslie · 2021 · Molecular Cell
80. Uncoupling T‐cell expansion from effector differentiation in cell‐based immunotherapy
    Joseph Garfield Crompton, Madhusudhanan Sukumar, Nicholas P. Restifo · 2013 · Immunological Reviews
81. β-Cell–Specific CD8 T Cell Phenotype in Type 1 Diabetes Reflects Chronic Autoantigen Exposure
    Ania Skowera, Kristin Ladell, James E. McLaren, Garry M. Dolton, Katherine K. Matthews, Emma Gostick D, Deborah Kronenberg‐Versteeg, Martin Eichmann, Robin R. Knight, Susanne Heck et al. · 2014 · Diabetes
82. Human epigenetic and transcriptional T cell differentiation atlas for identifying functional T cell-specific enhancers
    Josephine Ruth Giles, Sasikanth Manne, Elizabeth Freilich, Derek A. Oldridge, Amy E. Baxter, Sangeeth M. George, Zeyu Chen, Hua Huang, Lakshmi Chilukuri, Mary Carberry et al. · 2022 · Immunity
83. How does the timing of antiretroviral therapy initiation in acute infection affect HIV reservoirs?
    Jintanat Ananworanich, Karine Dubé, Nicolas Chomont · 2014 · Current Opinion in HIV and AIDS
84. Lineage relationship of CD8+ T cell subsets is revealed by progressive changes in the epigenetic landscape
    Joseph Garfield Crompton, Manikandan Narayanan, Suresh Cuddapah, Rahul Roychoudhuri, Yun Ji, Wenjing Yang, Shashank J. Patel, Madhusudhanan Sukumar, Douglas C. Palmer, Weiqun Peng et al. · 2015 · Cellular and Molecular Immunology
85. CD29 identifies IFN-γ–producing human CD8 + T cells with an increased cytotoxic potential
    Benoît P. Nicolet, Aurélie Guislain, Floris P. J. van Alphen, Raquel Gomez, Ton N. Schumacher, Maartje van den Biggelaar, Monika C. Wolkers · 2020 · Proceedings of the National Academy of Sciences
86. Tracking genetically engineered lymphocytes long-term reveals the dynamics of T cell immunological memory
    G. Oliveira, E. Ruggiero, M. Stanghellini, N. Cieri, M. D'Agostino, R. Fronza, Christina Lulay, Francesca Dionisio, S. Mastaglio, R. Greco et al. · 2015 · Science Translational Medicine
87. How to Train Your T Cells: Overcoming Immune Dysfunction in Multiple Myeloma
    Adam D. Cohen, Noopur S Raje, Jessica A. Fowler, Khalid Mezzi, Emma Scott, Madhav V. Dhodapkar · 2019 · Clinical Cancer Research
88. Targeting IL-21 to tumor-reactive T cells enhances memory T cell responses and anti-PD-1 antibody therapy
    Ying Li, Yanni Cong, Mingming Jia, Qianqian He, Haiqing Zhong, Yun Zhao, Hang Li, Meining Yan, Jia You, Jia Liu et al. · 2021 · Nature Communications
89. Improving CAR T-Cell Persistence
    Violena Pietrobon, Lauren Anne Todd, Anghsumala Goswami, Ofir Stefanson, Zhifen Yang, Francesco Maria Marincola · 2021 · International Journal of Molecular Sciences
90. Inhibition of Akt signaling promotes the generation of superior tumor-reactive T cells for adoptive immunotherapy
    Anniek B. van der Waart, Noortje M. P. van de Weem, Frans Maas, Cynthia S. M. Kramer, Michel G.D. Kester, J.H. Frederik Falkenburg, Nicolaas PM Schaap, Joop H. Jansen, Robbert van der Voort, Luca Gattinoni et al. · 2014 · Blood
91. Resident memory T cells are a cellular reservoir for HIV in the cervical mucosa
    Jon Cantero-Pérez, Judith Grau-Expósito, Carla Serra‐Peinado, Daniela Alexandra Rosero Freire, Laura Luque-Ballesteros, Antonio Astorga-Gamaza, Josep Castellví, Tamara Sanhueza, Gustavo Tapia, Belén Lloveras et al. · 2019 · Nature Communications
92. DNA scaffolds enable efficient and tunable functionalization of biomaterials for immune cell modulation
    Xiao Huang, Jasper Z. Williams, Ryan Chang, Zhongbo Li, Cassandra E. Burnett, Rogelio Antonio Hernández-López, Initha Setiady, Eric Gai, David M. Patterson, Wei Yu et al. · 2020 · Nature Nanotechnology
93. Vaccination establishes clonal relatives of germinal center T cells in the blood of humans
    Antje Heit, Frank Schmitz, Sarah E. Gerdts, Britta Flach, Miranda S. Moore, Jonathan A. Perkins, Harlan S. Robins, Alan A. Aderem, Paul W. Spearman, Georgia D. Tomaras et al. · 2017 · The Journal of Experimental Medicine
94. Human circulating and tissue-resident memory CD8+ T cells
    Marcus Buggert, David A. Price, Laura K. Mackay, Michael R. Betts · 2023 · Nature Immunology
95. Adoptive Therapy With Chimeric Antigen Receptor–Modified T Cells of Defined Subset Composition
    Stanley R. Riddell, Daniel Sommermeyer, Carolina Berger, Lingfeng Liu, Ashwini Balakrishnan, Alexander I. Salter, Michael Hudecek, David G. Maloney, Cameron John Turtle · 2014 · The Cancer Journal
96. Features of Effective T Cell-Inducing Vaccines against Chronic Viral Infections
    Eleni Panagioti, Paul Klenerman, Lian Ni Lee, Sjoerd H. van der Burg, Ramon Arens · 2018 · Frontiers in Immunology
97. Next-day manufacture of a novel anti-CD19 CAR-T therapy for B-cell acute lymphoblastic leukemia: first-in-human clinical study
    Junfang Yang, Jiaping He, Xian Zhang, Jingjing Li, Zhenguang Wang, Yongliang Zhang, Liyuan Qiu, Qionglu Wu, Zhe Sun, Xun Ye et al. · 2022 · Blood Cancer Journal
98. Different cytokine and stimulation conditions influence the expansion and immune phenotype of third-generation chimeric antigen receptor T cells specific for tumor antigen GD2
    Tessa Gargett, Michael Paul Brown · 2015 · Cytotherapy
99. Tumor-induced MDSC act via remote control to inhibit L-selectin-dependent adaptive immunity in lymph nodes
    Amy W. Ku, Jason B. Muhitch, Colin A. Powers, Michael R. Diehl, Minhyung Kim, Daniel T. Fisher, Anand P. Sharda, Virginia K. Clements, Kieran L. O’Loughlin, Hans Minderman et al. · 2016 · eLife
100. Regulation of CD8+ T Cells and Antitumor Immunity by Notch Signaling
     Shin‐ichi Tsukumo, Koji Yasutomo · 2018 · Frontiers in Immunology